Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose/Frequency Alglucosidase Alfa in Pompe Disease
NCT00483379Phase 4Completed
- Sponsor
- Sanofi
- Start
- May 2007
- Primary completion
- Dec 2009
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 4 trial of alglucosidase alfa in Pompe disease, sponsored by Sanofi. Started May 2007; status: completed.
02
Drugs
alglucosidase alfa
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT00483379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483379.